Go Pro
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel Free AMS Stock Alerts

Advanced Medical Solutions Group (AMS) Competitors

Advanced Medical Solutions Group logo
GBX 282 -0.50 (-0.18%)
As of 09:56 AM Eastern
Compare

AMS vs. NIOX, TSTL, EKF, SPEC, and CREO

Should you buy Advanced Medical Solutions Group stock or one of its competitors? Advanced Medical Solutions Group's main competitors and comparable companies include NIOX Group (NIOX), Tristel (TSTL), EKF Diagnostics (EKF), INSPECS Group (SPEC), and Creo Medical Group (CREO). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment & supplies" industry.

How does Advanced Medical Solutions Group compare to NIOX Group?

NIOX Group (LON:NIOX) and Advanced Medical Solutions Group (LON:AMS) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends, analyst recommendations and media sentiment.

NIOX Group has a beta of 0.92, meaning that its share price is 8% less volatile than the broader market. Comparatively, Advanced Medical Solutions Group has a beta of 0.704, meaning that its share price is 30% less volatile than the broader market.

7.6% of NIOX Group shares are owned by institutional investors. Comparatively, 21.5% of Advanced Medical Solutions Group shares are owned by institutional investors. 5.1% of NIOX Group shares are owned by company insiders. Comparatively, 4.0% of Advanced Medical Solutions Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

NIOX Group presently has a consensus price target of GBX 86, indicating a potential upside of 25.00%. Advanced Medical Solutions Group has a consensus price target of GBX 278.33, indicating a potential downside of 1.30%. Given NIOX Group's stronger consensus rating and higher probable upside, analysts plainly believe NIOX Group is more favorable than Advanced Medical Solutions Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NIOX Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Advanced Medical Solutions Group
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

NIOX Group has a net margin of 14.74% compared to Advanced Medical Solutions Group's net margin of 1.58%. NIOX Group's return on equity of 10.01% beat Advanced Medical Solutions Group's return on equity.

Company Net Margins Return on Equity Return on Assets
NIOX Group14.74% 10.01% 3.95%
Advanced Medical Solutions Group 1.58%1.44%2.35%

NIOX Group pays an annual dividend of GBX 1.25 per share and has a dividend yield of 1.8%. Advanced Medical Solutions Group pays an annual dividend of GBX 2.68 per share and has a dividend yield of 1.0%. NIOX Group pays out 76.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Advanced Medical Solutions Group pays out 59.3% of its earnings in the form of a dividend.

NIOX Group has higher earnings, but lower revenue than Advanced Medical Solutions Group. NIOX Group is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NIOX Group£47.50M6.10£995.88M£1.6441.95
Advanced Medical Solutions Group£228.94M2.68£11.22M£4.5262.39

In the previous week, NIOX Group had 1 more articles in the media than Advanced Medical Solutions Group. MarketBeat recorded 1 mentions for NIOX Group and 0 mentions for Advanced Medical Solutions Group. NIOX Group's average media sentiment score of 1.08 beat Advanced Medical Solutions Group's score of 1.01 indicating that NIOX Group is being referred to more favorably in the media.

Company Overall Sentiment
NIOX Group Positive
Advanced Medical Solutions Group Positive

Summary

NIOX Group beats Advanced Medical Solutions Group on 12 of the 17 factors compared between the two stocks.

How does Advanced Medical Solutions Group compare to Tristel?

Advanced Medical Solutions Group (LON:AMS) and Tristel (LON:TSTL) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment and valuation.

Advanced Medical Solutions Group has higher revenue and earnings than Tristel. Tristel is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Advanced Medical Solutions Group£228.94M2.68£11.22M£4.5262.39
Tristel£49.54M4.02£6.54M£16.2425.49

Advanced Medical Solutions Group pays an annual dividend of GBX 2.68 per share and has a dividend yield of 1.0%. Tristel pays an annual dividend of GBX 14.20 per share and has a dividend yield of 3.4%. Advanced Medical Solutions Group pays out 59.3% of its earnings in the form of a dividend. Tristel pays out 87.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

21.5% of Advanced Medical Solutions Group shares are held by institutional investors. Comparatively, 22.4% of Tristel shares are held by institutional investors. 4.0% of Advanced Medical Solutions Group shares are held by insiders. Comparatively, 21.0% of Tristel shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Advanced Medical Solutions Group has a beta of 0.704, indicating that its share price is 30% less volatile than the broader market. Comparatively, Tristel has a beta of 0.344, indicating that its share price is 66% less volatile than the broader market.

Advanced Medical Solutions Group presently has a consensus price target of GBX 278.33, indicating a potential downside of 1.30%. Given Advanced Medical Solutions Group's stronger consensus rating and higher possible upside, research analysts plainly believe Advanced Medical Solutions Group is more favorable than Tristel.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Advanced Medical Solutions Group
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33
Tristel
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Tristel has a net margin of 15.88% compared to Advanced Medical Solutions Group's net margin of 1.58%. Tristel's return on equity of 23.64% beat Advanced Medical Solutions Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Advanced Medical Solutions Group1.58% 1.44% 2.35%
Tristel 15.88%23.64%9.89%

In the previous week, Tristel had 1 more articles in the media than Advanced Medical Solutions Group. MarketBeat recorded 1 mentions for Tristel and 0 mentions for Advanced Medical Solutions Group. Advanced Medical Solutions Group's average media sentiment score of 1.01 beat Tristel's score of 0.00 indicating that Advanced Medical Solutions Group is being referred to more favorably in the media.

Company Overall Sentiment
Advanced Medical Solutions Group Positive
Tristel Neutral

Summary

Advanced Medical Solutions Group and Tristel tied by winning 9 of the 18 factors compared between the two stocks.

How does Advanced Medical Solutions Group compare to EKF Diagnostics?

Advanced Medical Solutions Group (LON:AMS) and EKF Diagnostics (LON:EKF) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk, profitability and media sentiment.

Advanced Medical Solutions Group currently has a consensus target price of GBX 278.33, indicating a potential downside of 1.30%. EKF Diagnostics has a consensus target price of GBX 35, indicating a potential upside of 41.22%. Given EKF Diagnostics' stronger consensus rating and higher possible upside, analysts plainly believe EKF Diagnostics is more favorable than Advanced Medical Solutions Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Advanced Medical Solutions Group
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33
EKF Diagnostics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Advanced Medical Solutions Group has a beta of 0.704, indicating that its share price is 30% less volatile than the broader market. Comparatively, EKF Diagnostics has a beta of 0.499, indicating that its share price is 50% less volatile than the broader market.

EKF Diagnostics has a net margin of 4.86% compared to Advanced Medical Solutions Group's net margin of 1.58%. EKF Diagnostics' return on equity of 3.58% beat Advanced Medical Solutions Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Advanced Medical Solutions Group1.58% 1.44% 2.35%
EKF Diagnostics 4.86%3.58%5.27%

21.5% of Advanced Medical Solutions Group shares are owned by institutional investors. Comparatively, 22.2% of EKF Diagnostics shares are owned by institutional investors. 4.0% of Advanced Medical Solutions Group shares are owned by insiders. Comparatively, 40.2% of EKF Diagnostics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, EKF Diagnostics had 1 more articles in the media than Advanced Medical Solutions Group. MarketBeat recorded 1 mentions for EKF Diagnostics and 0 mentions for Advanced Medical Solutions Group. Advanced Medical Solutions Group's average media sentiment score of 1.01 beat EKF Diagnostics' score of 0.00 indicating that Advanced Medical Solutions Group is being referred to more favorably in the media.

Company Overall Sentiment
Advanced Medical Solutions Group Positive
EKF Diagnostics Neutral

Advanced Medical Solutions Group has higher revenue and earnings than EKF Diagnostics. EKF Diagnostics is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Advanced Medical Solutions Group£228.94M2.68£11.22M£4.5262.39
EKF Diagnostics£51.35M2.07£4.68M£0.4752.73

Summary

EKF Diagnostics beats Advanced Medical Solutions Group on 8 of the 15 factors compared between the two stocks.

How does Advanced Medical Solutions Group compare to INSPECS Group?

Advanced Medical Solutions Group (LON:AMS) and INSPECS Group (LON:SPEC) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, earnings, dividends and valuation.

Advanced Medical Solutions Group presently has a consensus price target of GBX 278.33, indicating a potential downside of 1.30%. Given Advanced Medical Solutions Group's stronger consensus rating and higher possible upside, equities analysts plainly believe Advanced Medical Solutions Group is more favorable than INSPECS Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Advanced Medical Solutions Group
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33
INSPECS Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Advanced Medical Solutions Group has a beta of 0.704, indicating that its share price is 30% less volatile than the broader market. Comparatively, INSPECS Group has a beta of 1.603, indicating that its share price is 60% more volatile than the broader market.

Advanced Medical Solutions Group has higher revenue and earnings than INSPECS Group. INSPECS Group is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Advanced Medical Solutions Group£228.94M2.68£11.22M£4.5262.39
INSPECS Group£193.23M0.51-£4.11M-£9.40N/A

Advanced Medical Solutions Group has a net margin of 1.58% compared to INSPECS Group's net margin of -0.52%. Advanced Medical Solutions Group's return on equity of 1.44% beat INSPECS Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Advanced Medical Solutions Group1.58% 1.44% 2.35%
INSPECS Group -0.52%-1.19%0.45%

21.5% of Advanced Medical Solutions Group shares are owned by institutional investors. Comparatively, 0.2% of INSPECS Group shares are owned by institutional investors. 4.0% of Advanced Medical Solutions Group shares are owned by insiders. Comparatively, 19.6% of INSPECS Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Advanced Medical Solutions Group's average media sentiment score of 1.01 beat INSPECS Group's score of 0.00 indicating that Advanced Medical Solutions Group is being referred to more favorably in the media.

Company Overall Sentiment
Advanced Medical Solutions Group Positive
INSPECS Group Neutral

Summary

Advanced Medical Solutions Group beats INSPECS Group on 13 of the 15 factors compared between the two stocks.

How does Advanced Medical Solutions Group compare to Creo Medical Group?

Creo Medical Group (LON:CREO) and Advanced Medical Solutions Group (LON:AMS) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, dividends, risk, valuation, analyst recommendations, institutional ownership and media sentiment.

Creo Medical Group presently has a consensus target price of GBX 40, suggesting a potential upside of 312.37%. Advanced Medical Solutions Group has a consensus target price of GBX 278.33, suggesting a potential downside of 1.30%. Given Creo Medical Group's higher possible upside, analysts plainly believe Creo Medical Group is more favorable than Advanced Medical Solutions Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Creo Medical Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Advanced Medical Solutions Group
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

Creo Medical Group has a beta of 1.563854, meaning that its stock price is 56% more volatile than the broader market. Comparatively, Advanced Medical Solutions Group has a beta of 0.704, meaning that its stock price is 30% less volatile than the broader market.

44.1% of Creo Medical Group shares are held by institutional investors. Comparatively, 21.5% of Advanced Medical Solutions Group shares are held by institutional investors. 7.0% of Creo Medical Group shares are held by company insiders. Comparatively, 4.0% of Advanced Medical Solutions Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Advanced Medical Solutions Group has higher revenue and earnings than Creo Medical Group. Creo Medical Group is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Creo Medical Group£7M6.73-£25.04M£1.009.70
Advanced Medical Solutions Group£228.94M2.68£11.22M£4.5262.39

Creo Medical Group has a net margin of 88.33% compared to Advanced Medical Solutions Group's net margin of 1.58%. Creo Medical Group's return on equity of 9.56% beat Advanced Medical Solutions Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Creo Medical Group88.33% 9.56% -20.09%
Advanced Medical Solutions Group 1.58%1.44%2.35%

In the previous week, Creo Medical Group had 3 more articles in the media than Advanced Medical Solutions Group. MarketBeat recorded 3 mentions for Creo Medical Group and 0 mentions for Advanced Medical Solutions Group. Advanced Medical Solutions Group's average media sentiment score of 1.01 beat Creo Medical Group's score of 0.46 indicating that Advanced Medical Solutions Group is being referred to more favorably in the news media.

Company Overall Sentiment
Creo Medical Group Neutral
Advanced Medical Solutions Group Positive

Summary

Creo Medical Group and Advanced Medical Solutions Group tied by winning 8 of the 16 factors compared between the two stocks.

Get Advanced Medical Solutions Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for AMS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AMS vs. The Competition

Export
MetricAdvanced Medical Solutions GroupHealthcare Equipment & Supplies IndustryHealthcare SectorLON Exchange
Market Cap£613.65M£5.37B£7.18B£2.83B
Dividend Yield1.01%1.79%2.52%6.18%
P/E Ratio62.3924.82273.49366.33
Price / Sales2.6869.19657.0489,400.30
Price / Cash7.8732.8679.7527.89
Price / Book2.495.6510.426.38
Net Income£11.22M£149.51M£3.49B£5.89B
7 Day PerformanceN/A-1.68%-1.51%-0.23%
1 Month Performance0.53%-4.39%-4.71%11.59%
1 Year Performance25.33%4.42%10.76%16.78%

Advanced Medical Solutions Group Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AMS
Advanced Medical Solutions Group
0.9099 of 5 stars		GBX 282
-0.2%		GBX 278.33
-1.3%		+25.8%£613.65M£228.94M62.3910
NIOX
NIOX Group
2.4554 of 5 stars		GBX 67.80
+0.3%		GBX 86
+26.8%		-5.0%£285.35M£48.70M41.3492
TSTL
Tristel
N/AGBX 407.50
+0.6%		N/A+13.3%£195.90M£49.54M25.09208
EKF
EKF Diagnostics
1.9837 of 5 stars		GBX 26.70
+4.1%		GBX 35
+31.1%		-18.0%£114.32M£51.35M56.81356
SPEC
INSPECS Group
N/AGBX 92
-1.6%		N/A+134.5%£100.44M£193.23MN/A1,673

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:AMS) was last updated on 10/1/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...
Porter & Company | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Here’s Why Trump Won’t End The Iran War
Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...
Banyan Hill Publishing | Sponsoredtc pixel